Coherus Biosciences reported $-43126000 in EBITDA for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Aerie Pharmaceuticals AERI:US USD -25022000 8.43M
Akebia Therapeutics AKBA:US USD -38570000 96.43M
ALKERMES ALKS:US USD -41044000 25.98M
Alnylam Pharmaceuticals ALNY:US USD -247440000 65.85M
Amarin AMRN:US USD 56.56M 93.4M
Amgen AMGN:US USD 3.5B 62M
Baxter International BAX:US USD 855M 68M
Biogen BIIB:US USD 992.8M 82.9M
Biomarin Pharmaceutical BMRN:US USD 27.91M 36.51M
Bluebird Bio BLUE:US USD -85093000 14.32M
Bristol Myers Squibb BMY:US USD 5.32B 456M
Eli Lilly And LLY:US USD 2.31B 308.9M
Endo International Ordinary Shares ENDP:US USD 151.76M 22.28M
Fujifilm 4901:JP JPY 107.02B 22.4B
Gilead Sciences GILD:US USD 3.28B 731M
Horizon Pharma HZNP:US USD 287.24M 42.81M
Ironwood Pharmaceuticals IRWD:US USD 68.84M 12.82M
Myriad Genetics MYGN:US USD -31900000 27.1M
Pacira Pharmaceuticals PCRX:US USD 41.98M 7.94M
Perrigo Ordinary Shares PRGO:US USD 140.7M 54.6M
Pfizer PFE:US USD 10.52B 2.78B
Ptc Therapeutics PTCT:US USD -33710000 29.47M
Regeneron Pharmaceuticals REGN:US USD 1.33B 49.4M
Revance Therapeutics RVNC:US USD -72045000 19.65M
Sarepta Therapeutics SRPT:US USD -120652000 80.59M
Teva Pharmaceutical TEVA:IT USD 1.06B 31M
Vertex Pharmaceuticals VRTX:US USD 1.16B 6.8M
Xencor XNCR:US USD -36110000 10.33M
Zoetis ZTS:US USD 840M 14M